Medication Optimization Intervention for HIV/AIDS
(HIV-MOI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether people with HIV experience better health outcomes when their pharmacist accesses their full medical records. It focuses on African-Americans with HIV who also have diabetes or high blood pressure. Participants are divided into two groups: one receives standard care, while the other receives enhanced counseling based on their full medical history. This enhanced counseling is part of the medication optimization intervention. The study aims to determine if more information leads to better health results.
As an unphased trial, this study allows participants to contribute to research that could enhance personalized healthcare strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems the focus is on optimizing your medication management rather than changing your existing medications.
What prior data suggests that this medication optimization intervention is safe?
Research has shown that pharmacists can safely and effectively assist people living with HIV in managing their medications. In one study with 143 patients, pharmacist involvement reduced medication-related issues by 38.43%. This demonstrates that pharmacists can improve medication use without causing harm.
In this trial, pharmacists will access medical records to provide better counseling. The trial does not test new drugs; instead, it focuses on improving the use of current medications. This approach makes it a low-risk trial compared to those testing new drugs.
Overall, research supports that having pharmacists lead this approach is well-tolerated and can effectively aid in managing medications.12345Why are researchers excited about this trial?
Researchers are excited about the medication optimization intervention for HIV/AIDS because it focuses on a personalized approach to managing the condition. Unlike traditional treatments that strictly rely on prescribed medication regimens, this intervention involves providing pharmacists with access to patients' medical records. This allows for tailored adjustments to medication plans based on individual needs and responses. By enhancing communication between pharmacists and patients, the intervention aims to improve adherence to medication and overall health outcomes, offering a potentially more effective way to manage HIV/AIDS.
What evidence suggests that this medication optimization intervention is effective for improving health outcomes in African-Americans with HIV?
Research has shown that when pharmacists access patients' medical records, they can help improve the health of people with HIV. In this trial, participants in the Medication Optimization Intervention arm will have their medical records provided to the pharmacist, allowing for more personalized care. Studies have found that involving pharmacists leads to better medication habits and more effective control of the virus. Specifically, when pharmacists have more information, patients are more likely to take their medication correctly and manage their HIV better. One study found that when pharmacists are actively involved, people with HIV use their medications more effectively. These findings suggest that allowing pharmacists full access to medical records could help patients achieve better health outcomes.678910
Who Is on the Research Team?
Crystal K Hodge, PharmD
Principal Investigator
UNTHSC
Are You a Good Fit for This Trial?
This trial is for adult African-Americans with HIV who also have high blood pressure, type 2 diabetes, or both. Participants must be willing to share their medical records and not be pregnant or have a life expectancy of less than 2 years.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment and Enrollment
Participants' medical records are obtained and assessed; initial HIV-MOI visit conducted with individualized care plan development
Treatment
Participants receive either enhanced medication optimization or standard of care; follow-up visits occur at least quarterly
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Medication optimization intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Texas Health Science Center
Lead Sponsor
University of Minnesota
Collaborator
Walgreens, A Boots Alliance
Collaborator
Walgreens Boots Alliance
Collaborator
University of California, San Francisco
Collaborator